BSE Live
Oct 16, 16:01Prev. Close
180.75
Open Price
181.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 16, 15:59Prev. Close
180.71
Open Price
181.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
Cash Flow of Marksans Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 243.26 | 171.89 | 132.04 | 134.51 | 124.33 | |
Net CashFlow From Operating Activities | 31.02 | 34.05 | 51.73 | 50.97 | 107.07 | |
Net Cash Used In Investing Activities | 17.24 | -114.22 | -194.62 | -8.40 | 8.82 | |
Net Cash Used From Financing Activities | -29.92 | -26.22 | 210.02 | 75.86 | -13.53 | |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | 18.34 | -106.38 | 67.12 | 118.44 | 102.36 | |
Cash And Cash Equivalents Begin of Year | 41.93 | 148.31 | 81.19 | 105.61 | 3.35 | |
Cash And Cash Equivalents End Of Year | 60.27 | 41.93 | 148.31 | 224.05 | 105.71 |
09.09.2025
Marksans Pharma Standalone June 2025 Net Sales at Rs 319.73 crore, up 25.62% Y-o-Y
29.07.2025
07.07.2025
12.06.2025
09.09.2025
Marksans Pharma Standalone June 2025 Net Sales at Rs 319.73 crore, up 25.62% Y-o-Y
20.05.2025
Marksans Pharma Consolidated March 2025 Net Sales at Rs 708.46 crore, up 26.51% Y-o-Y
20.05.2025
Marksans Pharma Standalone March 2025 Net Sales at Rs 299.36 crore, up 32.93% Y-o-Y
28.02.2025
Marksans Pharma Consolidated December 2024 Net Sales at Rs 681.85 crore, up 16.33% Y-o-Y